相关实验视频

Updated: Sep 18, 2025

Comparison of Three Clinical Stereoscopic Methods for Measuring Binocular Visual Function During Amblyopic Treatment in Unilateral Amblyopia

Comparison of Three Clinical Stereoscopic Methods for Measuring Binocular Visual Function During Amblyopic Treatment in Unilateral Amblyopia

Published on: September 27, 2024

一项长度研究评估了0.01%的氨酸对近视儿童的影响 (RAMCOM-II研究)

Pradeep Agarwal¹, Veenu Maan¹, Ashi Khurana²

¹Department of Pediatric Ophthalmology, Strabismus and Neuro-Ophthalmology, CL Gupta Eye Institute, Moradabad, Uttar Pradesh, India.

Journal of current ophthalmology

|June 25, 2025

概括

低剂量阿特罗宾眼药 (0.01%) 在儿童中有效减缓近视的进展超过五年. 这种治疗在治疗儿科高近视方面表现出持续的疗效,与对照组相比,显著减少了折射误差.

科学领域:

眼科医生眼科眼科
儿科医学儿科医学
临床研究临床研究

背景情况:

在儿童中,高近视会在以后的生活中造成严重的眼睛疾病的重大风险.
有效的近视控制策略对于预防儿科患者长期视力障碍至关重要.
这项RAMCOM-II研究建立在先前的研究基础上,以评估长期低剂量氨酸治疗.

研究的目的:

为了评估0.01%的阿特罗宾眼滴在四年内给高近视儿童的安全性和有效性.
在一年的观察期后,评估阿特罗宾治疗的长期影响.

主要方法:

一项干预性,非随机化研究设计 (RAMCOM-II),涉及一年的基线观察.
两组:干预 (每天0.01%的阿特罗宾) 和控制 (没有治疗).
每年对近视进展,轴延长,视敏度,不良事件和合规性进行评估.

主要成果:

在4年后,与对照组相比,阿特罗平显著降低了近视进展 (2.0 D对3.2 D,P=0.01) 和轴延长.
在5年后观察到持续的疗效,近视进展的持续显著降低 (2.2D对3.4D,P=0.01).
他们强调了0.01%的阿特罗宾在治疗儿科高近视症方面的长期益处.

结论:

拉姆科姆-II研究证实了0.01%的阿特罗宾在五年内控制近视进展的有效性.
0.01%的氨酸为治疗儿童近视高的有前途的治疗方案.
持续使用低剂量氨酸是有效的长期治疗近视近视儿科患者.

关键词:

0.01% 亚氨酸亚氨酸五年后的跟进时间为5年.孩子孩子孩子孩子有效性有效性.高近视是指高近视的情况.拉姆科姆 (RAMCOM) 是一个非常重要的组织.安全的安全的安全的安全的安全.

更多相关视频

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Inducement and Evaluation of a Murine Model of Experimental Myopia

Inducement and Evaluation of a Murine Model of Experimental Myopia

Published on: January 22, 2019

相关概念视频

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...